Marc Bergeron

Marc Bergeron

marc.bergeron.2@ulaval.ca

Recent publications

Recent publications from the YDK lab are listed here

Gagnon M, Bergeron MJ, Perez-Sanchez J, Plasencia-Fernández I, Lorenzo L-, Godin AG, Castonguay A, Bonin RP, De Koninck Y. Reply to The small molecule CLP257 does not modify activity of the K+-Cl- co-transporter KCC2 but does potentiate GABAA receptor activity. Nat Med. 2017;23(12):1396-1398.
- PubMed
- DOI
- Google Scholar
- BibTex
- XML
- RIS
Bergeron MJ, Castonguay A, De Koninck Y. [KCC2: a new therapeutical target for the treatment of neurological diseases]. Med Sci (Paris). 2014;30(5):514-7.
- PubMed
- DOI
- Google Scholar
- BibTex
- XML
- RIS
Gagnon M, Bergeron MJ, Lavertu G, Castonguay A, Tripathy S, Bonin RP, Perez-Sanchez J, Boudreau D, Wang B, Dumas L, Valade I, Bachand K, Jacob-Wagner M, Tardif C, Kianicka I, Isenring P, Attardo G, Coull JA, De Koninck Y. Chloride extrusion enhancers as novel therapeutics for neurological diseases. Nat Med. 2013;19(11):1524-8.
- PubMed
- DOI
- Google Scholar
- BibTex
- XML
- RIS